Temporal changes of PIRADS scoring by radiologists and correlation to radical prostatectomy pathological outcomes

Barentsz, 2012, ESUR prostate MR guidelines 2012, Eur Radiol, 22, 746, 10.1007/s00330-011-2377-y Weinreb, 2016, PI-RADS prostate imaging - reporting and data system: 2015, version 2, Eur Urol, 69, 16, 10.1016/j.eururo.2015.08.052 Meng, 2016, Relationship between prebiopsy multiparametric magnetic resonance imaging (MRI), biopsy indication, and MRI-ultrasound fusion-targeted prostate biopsy outcomes, Eur Urol, 69, 512, 10.1016/j.eururo.2015.06.005 Rastinehad, 2015, Comparison of multiparametric MRI scoring systems and the impact on cancer detection in patients undergoing MR US fusion guided prostate biopsies, PLoS One, 10, 10.1371/journal.pone.0143404 Carlaw, 2017, Evaluation of the changing landscape of prostate cancer diagnosis and management from 2005 to 2016, Prostate Int, 5, 130, 10.1016/j.prnil.2017.04.005 Turkbey, 2019, Prostate imaging reporting and data system version 2.1: 2019 update of prostate imaging reporting and data system version 2, Eur Urol, 76, 340, 10.1016/j.eururo.2019.02.033 Kasivisvanathan, 2018, MRI-targeted or standard biopsy for prostate-cancer diagnosis, N Engl J Med, 378, 1767, 10.1056/NEJMoa1801993 Ahmed, 2017, Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study, Lancet, 389, 815, 10.1016/S0140-6736(16)32401-1 Sonn, 2019, Prostate magnetic resonance imaging interpretation varies substantially across radiologists, Eur Urol Focus, 5, 592, 10.1016/j.euf.2017.11.010 Rosenkrantz, 2017, The learning curve in prostate MRI interpretation: self-directed learning versus continual reader feedback, AJR Am J Roentgenol, 208, W92, 10.2214/AJR.16.16876 Schlenker, 2019, Comparison of PIRADS 3 lesions with histopathological findings after MRI-fusion targeted biopsy of the prostate in a real world-setting, Clin Hemorheol Microcirc, 71, 165, 10.3233/CH-189407 Meng, 2018, The institutional learning curve of magnetic resonance imaging-ultrasound fusion targeted prostate biopsy: temporal improvements in cancer detection in 4 years, J Urol, 200, 1022 Cata, 2021, Analyzing the learning curves of a novice and an experienced urologist for transrectal magnetic resonance imaging-ultrasound fusion prostate biopsy, Transl Androl Urol, 10, 1956, 10.21037/tau-21-8 Epstein, 2005, The 2005 international society of urological pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma, Am J Surg Pathol, 29, 1228, 10.1097/01.pas.0000173646.99337.b1 Edge, 2010, The American joint committee on cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM, Ann Surg Oncol, 17, 1471, 10.1245/s10434-010-0985-4 Muller, 2015, Prostate cancer: interobserver agreement and accuracy with the revised prostate imaging reporting and data system at multiparametric MR Imaging, Radiology, 277, 741, 10.1148/radiol.2015142818 Rosenkrantz, 2016, Interobserver reproducibility of the PI-RADS Version 2 Lexicon: A_ multicenter study of six experienced prostate radiologists, Radiology, 280, 793, 10.1148/radiol.2016152542 Greer, 2019, Interreader variability of prostate imaging reporting and data system version 2 in detecting and assessing prostate cancer lesions at prostate MRI, AJR Am J Roentgenol, 1 Greer, 2017, Accuracy and agreement of PIRADSv2 for prostate cancer mpMRI: a multireader study, J Magn Reson Imag, 45, 579, 10.1002/jmri.25372 Felker, 2016, In-bore magnetic resonance-guided transrectal biopsy for the detection of clinically significant prostate cancer, Abdom Radiol (NY), 41, 954, 10.1007/s00261-016-0750-7 Choi, 2019, Comparison of cancer detection rates between TRUS-guided biopsy and MRI-targeted biopsy according to PSA level in biopsy-naive patients: a propensity score matching analysis, Clin Genitourin Cancer, 17, e19, 10.1016/j.clgc.2018.09.007 Schoots, 2018, MRI in early prostate cancer detection: how to manage indeterminate or equivocal PI-RADS 3 lesions?, Transl Androl Urol, 7, 70, 10.21037/tau.2017.12.31 Hansen, 2017, Sub-differentiating equivocal PI-RADS-3 lesions in multiparametric magnetic resonance imaging of the prostate to improve cancer detection, Eur J Radiol, 95, 307, 10.1016/j.ejrad.2017.08.017 Steinkohl, 2018, Retrospective analysis of the development of PIRADS 3 lesions over time: when is a follow-up MRI reasonable?, World J Urol, 36, 367, 10.1007/s00345-017-2135-0 Yu, 1997, Detection of extracapsular extension of prostate carcinoma with endorectal and phased-array coil MR imaging: multivariate feature analysis, Radiology, 202, 697, 10.1148/radiology.202.3.9051019 Wibmer, 2015, Diagnosis of extracapsular extension of prostate cancer on prostate MRI: impact of second-opinion readings by subspecialized genitourinary oncologic radiologists, AJR Am J Roentgenol, 205, W73, 10.2214/AJR.14.13600 Matsuoka, 2017, Impact of the prostate imaging reporting and data system, version 2, on MRI diagnosis for extracapsular extension of prostate cancer, AJR Am J Roentgenol, 209, W76, 10.2214/AJR.16.17163 Kizilay, 2020, Prostate Int, 8, 10, 10.1016/j.prnil.2020.01.001 Gleave, 1996, Biochemical and pathological effects of 8 months of neoadjuvant androgen withdrawal therapy before radical prostatectomy in patients with clinically confined prostate cancer, J Urol, 155, 213 Van Poppel, 1995, Neoadjuvant hormonal therapy before radical prostatectomy decreases the number of positive surgical margins in stage T2 prostate cancer: interim results of a prospective randomized trial. The Belgian uro-oncological study group, J Urol, 154, 429 Gleave, 2001, Randomized comparative study of 3 versus 8-month neoadjuvant hormonal therapy before radical prostatectomy: biochemical and pathological effects, J Urol, 166, 500 Wegelin, 2019, The FUTURE trial: a multicenter randomised controlled trial on target biopsy techniques based on magnetic resonance imaging in the diagnosis of prostate cancer in patients with prior negative biopsies, Eur Urol, 75, 582, 10.1016/j.eururo.2018.11.040 Cho, 2020, Biparametric versus multiparametric magnetic resonance imaging of the prostate: detection of clinically significant cancer in a perfect match group, Prostate Int, 8, 146, 10.1016/j.prnil.2019.12.004 Song, 2021, A single-center long-term experience of active surveillance for prostate cancer: 15 years of follow-up, Investig Clin Urol, 62, 32, 10.4111/icu.20200206 Ahn, 2021, Clinical experience with active surveillance protocol using regular magnetic resonance imaging instead of regular repeat biopsy for monitoring: a study at a high-volume center in Korea, Prostate Int, 9, 90, 10.1016/j.prnil.2020.11.003